HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SNDA
Sonida Senior Living, Inc.
SNDA lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SNDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Weak |
SNDA's revenue is currently strong, but its profitability, cash flow and balance sheet are weak.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SNDA PE Valuation
SNDA has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SNDA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
SNDA has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over SNDA on earnings, with more consistent year-over-year improvement.
SNDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$5.36 | -$2.01 |
| Q2 2026 | -$6.20 | -$3.43 |
| Q1 2026 | -$5.84 | -$2.37 |
| Q4 2025 | -$4.22 | -$3.68 |
| Q3 2025 | -$3.35 | -$1.96 |
| Q2 2025 | -$2.77 | +$0.43 |
| Q1 2025 | -$3.47 | +$0.98 |
| Q4 2024 | -$0.54 | +$3.31 |
SNDA is still losing money, but far less than before: $5.36 per share over the past year, against $134.88 at its worst in late 2020.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SNDA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SNDA on profitability, with a higher operating margin.
SNDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $210.2M | +114% |
| Q2 2026 | $207.6M | +122% |
| Q1 2026 | $122.6M | +33% |
| Q4 2025 | $97.7M | +6.2% |
| Q3 2025 | $98M | +31% |
| Q2 2025 | $93.5M | +33% |
| Q1 2025 | $91.9M | +36% |
| Q4 2024 | $91.9M | +40% |
SNDA's revenue has grown year over year for 18 quarters in a row: $210M last quarter, up 114% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.3% | +6.5 points |
| Q2 2026 | -2.6% | -0.2 points |
| Q1 2026 | -24% | -46 points |
| Q4 2025 | -22% | -15 points |
| Q3 2025 | -16% | -9.2 points |
| Q2 2025 | -2.4% | -0.4 points |
| Q1 2025 | 22% | +25 points |
| Q4 2024 | -7% | -0.1 points |
SNDA's operating margin was −9.3% last quarter, up 6.5 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SNDA on cash generation, producing positive trailing cash flow while its opponent burns cash.
SNDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.6M | +360% |
| Q2 2026 | -$3.7M | -292% |
| Q1 2026 | -$42.6M | -$38.1M |
| Q4 2025 | -$9.3M | +$1.1M |
| Q3 2025 | $3M | +$8M |
| Q2 2025 | $1.9M | +$3.6M |
| Q1 2025 | -$4.5M | +$5.4M |
| Q4 2024 | -$10.4M | -$6.6M |
SNDA has burned cash in most quarters: −$42M over the past year, against −$10M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SNDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SNDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +821K shares |
| 1 year | +163% | +29.5M shares |
| 3 years | +649% | +41.3M shares |
| 5 years | +2077% | +45.4M shares |
SNDA has 48M diluted shares, up 163% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2022 | $44,000 |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SNDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 32.9x | High |
| Q2 2026 | 72.2x | High |
| Q4 2025 | 18.1x | High |
| Q3 2025 | 13.0x | High |
| Q2 2025 | 11.5x | High |
| Q1 2025 | 11.5x | High |
| Q4 2024 | 21.7x | High |
| Q3 2024 | 20.8x | High |
SNDA's net debt is more than 20 years of its operating earnings (EBITDA), up from 11 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SNDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 9.7 | Oversold |
SNDA's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SNDA PE vs Healthcare Sector
| Metric | SNDA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SNDA has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SNDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.0 | 5.3% below |
| 20 week MA | $37.9 | 12% below |
| 50 week MA | $35.7 | 7% below |
| 100 week MA | $30.4 | 9.1% above |
| 200 week MA | $23.7 | 40% above |
SNDA has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SNDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.6 | $12.9 | -73% |
| 2021 | $12.9 | $28.6 | +122% |
| 2022 | $28.6 | $11.7 | -59% |
| 2023 | $11.7 | $9.66 | -17% |
| 2024 | $9.66 | $22.9 | +137% |
| 2025 | $22.9 | $32.3 | +41% |
| 2026 YTD | $32.3 | $33.2 | +2.8% |
SNDA has the edge over HIMS on returns for 2026, with the stronger performance.